Hôpital de Rangueil

corporate_fareorganization

Hôpital de Rangueil

- Funding / Projects
  (24)

24 Projects, page 1 of 5

Prospective construction and validation of a prognostic score to idendify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival.
assignment_turned_inProjectPartners:Institut de Cancérologie de l'Ouest, Centre Georges-François Leclerc, Hôpital Morvan, Hôpital de Rangueil, Centre Eugène Marquis +3 partners
Institut de Cancérologie de l'Ouest,
Centre Georges-François Leclerc,
Hôpital Morvan,
Hôpital de Rangueil,
Centre Eugène Marquis,
AMU,
Institut Claudius Regaud,
Institut Curie
Funder: Institut National du Cancer Project Code: INCa-DGOS-3718
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line
assignment_turned_inProjectPartners:Groupe Hospitalier Pitié Salpétrière, ICM-VAL D'AURELLE, Centre Hospitalier Régional et Universitaire de Lille, Délégation à la Recherche et à lInnovation - CHU Angers, Centre Léon Bérard +17 partners
Groupe Hospitalier Pitié Salpétrière,
ICM-VAL D'AURELLE,
Centre Hospitalier Régional et Universitaire de Lille,
Délégation à la Recherche et à lInnovation - CHU Angers,
Centre Léon Bérard,
CHUG,
Institut Bergonié,
Hôpital Côte de Nacre,
Hôpital Jean Minjoz,
Polyclinique de Courlancy,
Centre Hospitalier de Colmar,
Hôpital Central,
Hôpital Dupuytren,
Délégation à la Recherche Clinique et à Iinnovation - CHRU de Brest,
CHUAP,
Hôpital le Bocage,
Centre Hospitalier Universitaire de Rennes,
Hôpital de Rangueil,
Centre Henri Becquerel,
Centre Hospitalier Universitaire de Tours,
Hôpital René Huguenin - Institut Curie,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-7342
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
BACAP Project
assignment_turned_inProject2013 - 2016Partners:Assistance Publique - Hôpitaux de Marseille (AP-HM), Groupe francophone Thrombose et Cancer, Centre Hospitalier Universitaire de Toulouse, ICM-VAL D'AURELLE, Hôpital privé Jean Mermoz +7 partners
Assistance Publique - Hôpitaux de Marseille (AP-HM),
Groupe francophone Thrombose et Cancer,
Centre Hospitalier Universitaire de Toulouse,
ICM-VAL D'AURELLE,
Hôpital privé Jean Mermoz,
Registre Bourguignon des cancers digestifs,
Institut Paoli-Calmettes- (IPC),
Hôpital Beaujon,
INSERM U1027,
Hôpital de Rangueil,
Institut Gustave Roussy,
Hôpital de l'Archet
Funder: Institut National du Cancer Project Code: INCa-6294
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
PHASE 2 GENE THERAPY TRIAL OF LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA USING INTRATUMOUR INJECTION OF CYL-02 IN COMBINATION OF GEMCITABINE (THERGAP-02 TRIAL)
assignment_turned_inProjectPartners:Institut Paoli-Calmettes- (IPC), Hôpital Nord, Hôpital Saint Eloi, Hôpital de Rangueil, Hôpital Beaujon +1 partners
Institut Paoli-Calmettes- (IPC),
Hôpital Nord,
Hôpital Saint Eloi,
Hôpital de Rangueil,
Hôpital Beaujon,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-7201
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
RECLAIM: Response of natural killer cells against multiple myeloma
assignment_turned_inProjectUntil 2022Partners:Hôpital de Rangueil, CNRS UMR5308 -INSERM U1111, CNRS ERL 5294 - INSERM UPS UMR 1037
Hôpital de Rangueil,
CNRS UMR5308 -INSERM U1111,
CNRS ERL 5294 - INSERM UPS UMR 1037
Funder: Institut National du Cancer Project Code: INCa-13781
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Hôpital de Rangueil

Hôpital de Rangueil

24 Projects, page 1 of 5

Prospective construction and validation of a prognostic score to idendify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival.

BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line

BACAP Project

PHASE 2 GENE THERAPY TRIAL OF LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA USING INTRATUMOUR INJECTION OF CYL-02 IN COMBINATION OF GEMCITABINE (THERGAP-02 TRIAL)

RECLAIM: Response of natural killer cells against multiple myeloma

Loading